Skip to main content

NEUROCRINE BIOSCIENCES INC

For the period ended May 22, 2024. Filed Apr 10, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

May 22, 2024 · Filed Apr 10, 2024

NBIX$164.63+3.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Proxy Summary

This summary highlights information that is described in more detail elsewhere in this proxy statement. This summary does not contain all the information you should consider before you vote, and you should read the entire proxy statement carefully before voting.

General Information

Annual Meeting of Stockholders
Meeting Date:May 22, 2024
Time:10:30 a.m. Local Time
Place:6027 Edgewood Bend Court, San Diego, California 92130
Record Date:March 25, 2024

How to Vote

Your vote is very important. Whether or not you plan to attend the Annual Meeting, we hope you will vote as soon as possible. You may vote in the following ways:

Telephone: Call 1-800-690-6903 from any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the meeting date. Have your proxy card in hand when you call and then follow the instructions. Easy-to-follow voice prompts allow you to submit your proxy and confirm your instructions have been properly recorded.

Internet: Visit www.proxyvote.com to transmit your voting instructions and for electronic delivery of information via the Internet up until 11:59 P.M. Eastern Time the day before the meeting date. As with telephone voting, you can confirm that your instructions have been properly recorded.

Mail: Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

Matters to be Voted On

MatterBoard of DirectorsRecommendationPage Reference forMore Information
Proposal One: Elect Class I DirectorsFOR all nominees22
Proposal Two: Advisory vote on executive compensationFOR24
Proposal Three: Approve an amendment to the Company’s 2020 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 3,635,000 sharesFOR25
Proposal Four: Ratify Ernst & Young LLP as independent registered public accounting firmFOR38
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.